CERALASERTIB: 33 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
33
Total FAERS Reports
4 (12.1%)
Deaths Reported
23
Hospitalizations
33
As Primary/Secondary Suspect
11
Life-Threatening
2
Disabilities
First Report: 20160212 · Latest Report: 20230914
What Are the Most Common CERALASERTIB Side Effects?
#1 Most Reported
Thrombocytopenia
6 reports (18.2%)
#2 Most Reported
Platelet count decreased
6 reports (18.2%)
#3 Most Reported
Febrile neutropenia
4 reports (12.1%)
All CERALASERTIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Platelet count decreased | 6 | 18.2% | 1 | 3 |
| Thrombocytopenia | 6 | 18.2% | 1 | 4 |
Who Reports CERALASERTIB Side Effects? Age & Gender Data
Gender: 54.7% female, 45.3% male. Average age: 58.6 years. Most reports from: GB. View detailed demographics →
Is CERALASERTIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2016 | 2 | 0 | 2 |
| 2017 | 4 | 0 | 4 |
| 2018 | 2 | 0 | 1 |
| 2019 | 4 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 5 | 2 | 5 |
| 2022 | 7 | 1 | 3 |
| 2023 | 8 | 1 | 5 |
What Is CERALASERTIB Used For?
| Indication | Reports |
|---|---|
| Neoplasm | 11 |
| Non-small cell lung cancer | 7 |
Official FDA Label for CERALASERTIB
Official prescribing information from the FDA-approved drug label.